OKUR

OnKure Therapeutics

58 hedge funds and large institutions have $208M invested in OnKure Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0.3% more ownership

Funds ownership: 7.79%8.09% (+0.3%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

60% less call options, than puts

Call options by funds: $8K | Put options by funds: $20K

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
$20K
Net Calls
Net Calls Change

Top Buyers

1 +$3.42M
2 +$2.5M
3 +$1.54M
4
BlackRock
BlackRock
New York
+$1.23M
5
Franklin Resources
Franklin Resources
California
+$1.13M

Top Sellers

1 -$1.34M
2 -$1.15M
3 -$1.02M
4
OCA
Octagon Capital Advisors
New York
-$676K
5
Walleye Capital
Walleye Capital
New York
-$325K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$6.08K
52
$4.04K
53
$4K
54
$2.76K
55
$2K
56
$1.8K
57
$762
58
$735
59
60
61
62